Published in partnership with High Level Data, a D.C. based cannabis data publisher. This monthly data feature will be available to Outlaw Report supporters two weeks early. Sign up today.
That oversaturation is reflected in sales data. In August 2025, D.C. dispensaries averaged only $101,000 in monthly medical sales, roughly half of Maryland’s average and a fraction of Pennsylvania’s. Despite the fierce competition, prices remain high at about $10.92 per gram, suggesting that supply is outpacing patient demand rather than driving costs down.
Other states with more controlled licensing systems have seen steadier markets. Experts say D.C. may need to strike a better balance between access, regulation, and demand — or risk the same instability now plaguing many U.S. cannabis markets.
Washington, D.C.’s medical cannabis industry is expanding rapidly — but the growth may not be sustainable. The city now counts 54 licensed dispensaries for just over 700,000 residents as of August, giving it far more stores per capita than nearby states like Maryland, Pennsylvania or Rhode Island.
That oversaturation is reflected in sales data. In August 2025, D.C. dispensaries averaged only $101,000 in monthly medical sales, roughly half of Maryland’s average and a fraction of Pennsylvania’s. Despite the fierce competition, prices remain high at about $10.92 per gram, suggesting that supply is outpacing patient demand rather than driving costs down.
Other states with more controlled licensing systems have seen steadier markets. Experts say D.C. may need to strike a better balance between access, regulation, and demand — or risk the same instability now plaguing many U.S. cannabis markets.
